CoChat

The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network

Open access
Tan, Xiaochao, Banerjee, Priyam, Liu, Xin, Yu, Jiang, Gibbons, Don L., Wu, Ping, Scott, Kenneth L., Diao, Lixia, Zheng, Xiaofeng, Wang, Jing, Jalali, Ali, Suraokar, Milind, Fujimoto, Junya, Behrens, Carmen, Liu, Xiuping, Liu, Chang-gong, Creighton, Chad J., Wistuba, Ignacio I., Kurie, Jonathan M. · 2018 · Journal of Clinical Investigation
Cited by 68

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Epithelial tumor cells undergo epithelial-to-mesenchymal transition (EMT) to gain metastatic activity. Competing endogenous RNAs (ceRNAs) have binding sites for a common set of microRNAs (miRs) and regulate each other's expression by sponging miRs. Here, we address whether ceRNAs govern metastasis driven by the EMT-activating transcription factor ZEB1. High miR-181b levels were correlated with an improved prognosis in human lung adenocarcinomas, and metastatic tumor cell lines derived from a murine lung adenocarcinoma model in which metastasis is ZEB1-driven were enriched in miR-181b targets. ZEB1 relieved a strong basal repression of α1 integrin (ITGA1) mRNA, which in turn upregulated adenylyl cyclase 9 mRNA (ADCY9) by sponging miR181b. Ectopic expression of the ITGA1 3'-untranslated region reversed miR-181b-mediated metastasis suppression and increased the levels of adenylyl cyclase 9 protein (AC9), which promoted tumor cell migration and metastasis. In human lung adenocarcinomas, ITGA1 and ADCY9 levels were positively correlated, and an AC9-activated transcriptomic signature had poor-prognostic value. Thus, ZEB1 initiates a miR-181b-regulated ceRNA network to drive metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci97225

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 68

Metadata

Authors
Tan, X., Banerjee, P., Liu, X., Yu, J., Gibbons, D. L., Wu, P., Scott, K. L., Diao, L., Zheng, X., Wang, J., Jalali, A., Suraokar, M., Fujimoto, J., Behrens, C., Liu, X., Liu, C.-G., Creighton, C. J., Wistuba, I. I., & Kurie, J. M.
Venue
Journal of Clinical Investigation
Published
2018-02-26
Volume
128
Issue
4
Pages
1267-1282
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2783055234
Cited by
68
References
7
FWCI
3.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. https://app.cochat.ai/papers/10.1172/jci97225
The paper
Tan, X., Banerjee, P., Liu, X., Yu, J., Gibbons, D. L., Wu, P., Scott, K. L., Diao, L., Zheng, X., Wang, J., Jalali, A., Suraokar, M., Fujimoto, J., Behrens, C., Liu, X., Liu, C.-G., Creighton, C. J., Wistuba, I. I., & Kurie, J. M. (2018). The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. Journal of Clinical Investigation. https://doi.org/10.1172/jci97225

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.